Effect of cytochrome P450-dependent epoxyeicosanoids on Ristocetin-induced thrombocyte aggregation

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Hemorheology and Microcirculation

• Publication date

  2012-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3233/CH-2012-1614PMID 22975950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel.

  2011cited by this paper
• High-dose atorvastatin treatment in patients with peripheral arterial disease: Effects on platelet aggregation, blood rheology and plasma homocysteine

  2011cited by this paper
• Gasotransmitters and platelets.

  2011cited by this paper
• Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids.

  2011cited by this paper
• Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity.

  2011cited by this paper
• Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome

  2011cited by this paper
• A sulfaphenazole-sensitive EDHF opposes platelet-endothelium interactions in vitro and in the hamster microcirculation in vivo.

  2010cited by this paper
• Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids*

  2010cited by this paper
• Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study.

  2010cited by this paper
• Degradable, Multifunctional Cardiovascular Implants: Challenges and Hurdles

  2010cited by this paper
• Ethical Guidelines for Publication in Clinical Hemorheology and Microcirculation

  2010cited by this paper
• Epoxyeicosatrienoic acid analogs and vascular function.

  2010cited by this paper
• New guidelines for hemorheological laboratory techniques

  2009cited by this paper
• Ein Cytochrom P450 2C8/9-abhängig gebildeter EDHF hyperpolarisiert Thrombozyten und hemmt deren Adhäsion an Endothelzellen

  2008cited by this paper
• 11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells.

  2007cited by this paper
• Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors.

  2007cited by this paper
• Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.

  2007cited by this paper
• Action of epoxyeicosatrienoic acids on cellular function.

  2007cited by this paper
• The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.

  2007cited by this paper
• The vasodilator 17,18‐epoxyeicosatetraenoic acid targets the pore‐forming BK α channel subunit in rodents

  2007cited by this paper
• Epoxyeicosatrienoic acids, cell signaling and angiogenesis.

  2007cited by this paper
• 11,12-Epoxyeicosatrienoic acid activates the l-arginine/nitric oxide pathway in human platelets

  2007cited by this paper
• von Willebrand factor mediates platelet spreading through glycoprotein Ib and αIIbβ3 in the presence of botrocetin and ristocetin, respectively

  2006cited by this paper
• Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

  2006cited by this paper
• Membrane Potential-Dependent Inhibition of Platelet Adhesion to Endothelial Cells by Epoxyeicosatrienoic Acids

  2004cited by this paper
• Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation.

  2004cited by this paper
• Influence of the direct NO‐donor SIN‐1 on the interaction between platelets and stainless steel stents under dynamic conditions

  2003cited by this paper
• Endothelium-Derived Hyperpolarizing Factor in Human Internal Mammary Artery Is 11,12-Epoxyeicosatrienoic Acid and Causes Relaxation by Activating Smooth Muscle BKCa Channels

  2003cited by this paper
• Glycoprotein Ib-IX-V.

  2003cited by this paper
• Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels.

  2002cited by this paper
• Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators

  2002influential reference
• Molecules in Focus

  2002cited by this paper
• P-450 metabolites of arachidonic acid in the control of cardiovascular function.

  2002cited by this paper
• EET homologs potently dilate coronary microvessels and activate BK(Ca) channels.

  2001cited by this paper
• Inhibition of Cyclooxygenase Activity and Platelet Aggregation by Epoxyeicosatrienoic Acids

  2001cited by this paper
• Is EDHF an epoxyeicosatrienoic acid?

  2000cited by this paper
• Cytochrome P450 2C is an EDHF synthase in coronary arteries

  1999cited by this paper
• Ristocetin-mediated interaction of human von Willebrand factor with platelet glycoprotein lb evokes a transient calcium signal: observations with Fura-PE3.

  1998cited by this paper
• Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels.

  1998cited by this paper
• Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo.

  1998cited by this paper
• Identification of arachidonate P-450 metabolites in human platelet phospholipids.

  1995cited by this paper
• Epoxygenase metabolites of docosahexaenoic and eicosapentaenoic acids inhibit platelet aggregation at concentrations below those affecting thromboxane synthesis.

  1995cited by this paper
• Platelet Activation: Signal Transduction Via Membrane Receptors

  1995cited by this paper
• Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase.

  1993cited by this paper
• Epoxyeicosatrienoic acids inhibit Ca2+ entry into platelets stimulated by thapsigargin and thrombin.

  1992cited by this paper
• 14,15‐Epoxyeicosatrienoic Acid Inhibits Platelet Aggregation in Mouse Cerebral Arterioles

  1991cited by this paper
• Ultrastructure of the interaction between human platelets and polymerizing fibrin within the first minutes of clot formation.

  1990cited by this paper
• Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein

  1989cited by this paper
• Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex.

  1988cited by this paper
• Histamine stimulation of prostaglandin and HETE synthesis in human endothelial cells.

  1988cited by this paper
• Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry.

  1986cited by this paper
• Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.

  1985cited by this paper
• Platelet Membrane Potential: Simultaneous Measurement of diSC3(5) Fluorescence and Optical Density

  1985cited by this paper
• Platelet glycoproteins.

  1984cited by this paper
• The effect of altered transmembrane ion gradients on membrane potential and aggregation of human platelets in blood plasma.

  1981cited by this paper
• Binding of Factor VIII to Platelets in the Presence of Ristocetin

  1977cited by this paper
• Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.

  1976cited by this paper
• Role of surface glycoproteins in human platelet function.

  1976cited by this paper
• Studies on the mechanism of ristocetin-induced platelet aggregation.

  1975cited by this paper
• The aggregation of blood platelets

  1963cited by this paper

• The polyunsaturated fatty acid and oxylipin plasma signature of aneurysmal subarachnoid haemorrhage, case-control study

  2025cites this paper
• Differential Effects of 17,18-EEQ and 19,20-EDP Combined with Soluble Epoxide Hydrolase Inhibitor t-TUCB on Diet-Induced Obesity in Mice

  2021influential citation
• Biochemical and structural characterization of two cif-like epoxide hydrolases from Burkholderia cenocepacia

  2021cites this paper
• Effects of gut microbial metabolite trimethylamine N-oxide (TMAO) on platelets and endothelial cells

  2020cites this paper
• The Association Between Vascular Inflammation and Depressive Disorder. Causality, Biomarkers and Targeted Treatment

  2020cites this paper
• Effects and mechanism of arachidonic acid against TNF-α induced apoptosis of endothelial cells

  2020cites this paper
• Vascular Endothelial Cell Biology: An Update

  2019cites this paper
• Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research

  2019cites this paper
• The pleiotropic effects of antiplatelet therapies

  2019cites this paper
• Metabolism of polyunsaturated fatty acids and their oxylipins

  2019cites this paper
• DHA and 19,20-EDP induce lysosomal-proteolytic-dependent cytotoxicity through de novo ceramide production in H9c2 cells with a glycolytic profile

  2018cites this paper
• Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting

  2018cites this paper
• Omega‐3 fatty acids in coronary heart disease: Recent updates and future perspectives

  2018cites this paper
• Dietary modulation of oxylipins in cardiovascular disease and aging.

  2017cites this paper
• Effect of DHA supplementation on oxylipin levels in plasma and immune cell stimulated blood.

  2017cites this paper
• Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects.

  2016cites this paper
• Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

  2015influential citation
• The production of ω-hydroxy palmitic acid using fatty acid metabolism and cofactor optimization in Escherichia coli

  2015cites this paper
• Role of CYP eicosanoids in the regulation of pharyngeal pumping and food uptake in Caenorhabditis elegans[S]

  2015cites this paper
• Basal and inducible anti-inflammatory epoxygenase activity in endothelial cells

  2014cites this paper
• Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins.

  2014cites this paper
• Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men.

  2014cites this paper
• Prostaglandins and Other Lipid Mediators omparison of the effects of long-chain omega-3 fatty acid upplementation on plasma levels of free and esterified oxylipins ils

  2014cites this paper
• Increase of EPA-derived hydroxy, epoxy and dihydroxy fatty acid levels in human plasma after a single dose of long-chain omega-3 PUFA.

  2014cites this paper
• Epoxyeicosatrienoic acids and cardioprotection: the road to translation.

  2014cites this paper
• ncrease of EPA-derived hydroxy , epoxy and dihydroxy fatty acid evels in human plasma after a single dose of long-chain omega-3 UFA an

  2014cites this paper